US 11278572
Reducing CXCR4 expression and/or function to enhance engraftment of hematopoietic stem cells
granted A61KA61K35/28A61K45/06
Quick answer
US patent 11278572 (Reducing CXCR4 expression and/or function to enhance engraftment of hematopoietic stem cells) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Mar 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K35/28, A61K45/06, A61P, A61P31/18